Prot #IMGN632-0802: A Phase 1b/2 Study of IMGN632 as Monotherapy or Combination with Venetoclax and/or Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia

Project: Research project

Project Details

StatusActive
Effective start/end date6/4/206/4/23

Funding

  • Precision Oncology, LLC (Prot #IMGN632-0802)
  • ImmunoGen, Inc. (Prot #IMGN632-0802)